CAS 456-42-8|3-Fluorobenzyl chloride
Introduction：Basic information about CAS 456-42-8|3-Fluorobenzyl chloride, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 3-Fluorobenzyl chloride | ||
|---|---|---|---|
| CAS Number | 456-42-8 | Molecular Weight | 144.574 |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 173.3±15.0 °C at 760 mmHg |
| Molecular Formula | C7H6ClF | Melting Point | / |
| MSDS | ChineseUSA | Flash Point | 58.9±0.0 °C |
| Symbol | GHS02, GHS05 | Signal Word | Danger |
Names
| Name | 3-Fluorobenzyl chloride |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 173.3±15.0 °C at 760 mmHg |
| Molecular Formula | C7H6ClF |
| Molecular Weight | 144.574 |
| Flash Point | 58.9±0.0 °C |
| Exact Mass | 144.014206 |
| LogP | 2.54 |
| Vapour Pressure | 1.7±0.3 mmHg at 25°C |
| Index of Refraction | 1.505 |
| InChIKey | XBDXMDVEZLOGMC-UHFFFAOYSA-N |
| SMILES | Fc1cccc(CCl)c1 |
| Water Solubility | 40 g/L (20 ºC) |
Safety Information
| Symbol | GHS02, GHS05 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H226-H314 |
| Precautionary Statements | P280-P305 + P351 + P338-P310 |
| Personal Protective Equipment | Faceshields;full-face respirator (US);Gloves;Goggles;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | C:Corrosive |
| Risk Phrases | R34 |
| Safety Phrases | S26-S36/37/39-S45 |
| RIDADR | UN 2920 8/PG 2 |
| WGK Germany | 3 |
| Packaging Group | III |
| Hazard Class | 3 |
| HS Code | 29036990 |
Customs
| HS Code | 2903999090 |
|---|---|
| Summary | 2903999090 halogenated derivatives of aromatic hydrocarbons VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |
Articles3
More Articles| Truncated structures used in search for new lead compounds and in a retrospective analysis of thienopyrimidine-based EGFR inhibitors. Eur. J. Med. Chem. 94 , 175-94, (2015) An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This... | |
| Distributed Drug Discovery, Part 3: using D(3) methodology to synthesize analogs of an anti-melanoma compound. J. Comb. Chem. 11(1) , 34-43, (2009) For the successful implementation of Distributed Drug Discovery (D(3)) (outlined in the accompanying Perspective), students, in the course of their educational laboratories, must be able to reproducib... | |
| Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction. J. Comb. Chem. 11 , 14-33, (2009) Distributed Drug Discovery (D(3)) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computationa... |
Synonyms
| Toluene, α-chloro-3-fluoro- |
| MFCD00000904 |
| 1-(Chloromethyl)-3-fluorobenzene |
| Benzene, 1-(chloromethyl)-3-fluoro- |
| Toluene, α-chloro-m-fluoro- |
| α-Chloro-3-fluorotoluene |
| G1R CF |
| EINECS 207-264-8 |
| m-Fluorobenzyl chloride |
| α-Chloro-m-fluorotoluene |
